SEARCH

SEARCH BY CITATION

References

  • 1
    Grossmann M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, Lupien PJ. et al. Sucessful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nat Genet 1994; 6: 335341.
  • 2
    Chang AGY, Wu GY. Gene therapy: applications to the treatment of gastrointestinal and liver diseases. Gastroenterology 1994; 106: 10761084.
  • 3
    Engelhardt JF, Xuehai Y, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response to mouse liver. Proc Natl Acad Sci U S A 1994; 91: 61966200.
  • 4
    Gloss El, Borel Rinkes IHM, Bader A, Yarmush ML, Cunningham JM. Retroviral infection and expression of cationic amino acid transporters in rodent hepatocytes. J Virol 1993; 67: 20972102.
  • 5
    Wu JY, Robinson D, Kung H-J, Hatzoglou M. Hormonal regulation of the gene for the type C ecotropic retrovirus receptor in rat liver cells. J Virol 1994; 68: 16151623.
  • 6
    Miller DG, Edwards RH, Miller AD. Cloning of the cellular receptor for the amphotropic murine retrovirus reveals homology to hat for gibbon ape leukemia virus. Proc Natl Acad Sci USA 1994; 91: 7882.
  • 7
    Van Zeijl M, Johan SV, Gloss E, Cunningham J, Eddy R, Shows TB, O'Hara B. A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc Natl Acad Sci U S A 1994; 91: 11691172.
  • 8
    Sandgren EP, Palmiter RD, Heckel JL, Daugherty CC, Brinster RL, Degen JL. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991; 66: 245256.
  • 9
    Sandgren EP, Palmiter RD, Heckel JL, Brinster RL, Degen JL. DNA rearrangement causes hepatocarcinogenesis in albumin-plasminogen activator transgenic mice. Proc Natl Acad Sci USA 1992; 89: 1152311527.
  • 10
    Lochmueller H, Jani A, Huard J, Prescott S, Simoneau M, Massie B, Karpati G. et al. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (ΔE1 + ΔE3) during multiple passages in 293 cells. Hum Gene Ther 1995; 5: 14851491.